A significant change to hepatitis B prescribing comes into effect from 1 September 2026. Currently, these medications require a specialist to be able to prescribe treatment. Moving forward, medical and nurse practitioners will no longer need this specialist s100 accreditation to prescribe.
Treatment for hepatitis B
Hepatitis B requires ongoing monitoring and, for some people, long-term treatment. Expanding the number of clinicians who can prescribe means treatment can be provided as part of routine primary care, closer to where people live and with greater continuity of care.
This change also supports the direction of the Fourth National Hepatitis B Strategy 2025–2030, which aims to eliminate hepatitis B as a public health threat by 2030. Increasing access to diagnosis and treatment is essential if that ambition is to be achieved.
If you have any questions about hepatitis B, you can call HepLink – Australia’s free and confidential hepatitis service at 1800 437 222.
Are you a healthcare practitioner looking to prescribe hepatitis B treatment visit here.